Mundipharma International has hired advertising agency VCCP Health, part of Chime Communications, to drive new product launches across its network of European independent associated companies.
This is the first time Mundipharma has hired VCCP Health for any of its business areas, and VCCP Health’s first priority will be to develop a campaign for chemotherapy Levact (bendamustine).
Georg Toufar, Mundipharma’s chief marketing officer and board director said: “The Mundipharma network of independent associated companies is bringing a range of new treatments to the European market that will benefit patients and deliver value for payers. We have a wonderful story to tell, and with VCCP Health we will be working with a wonderful storyteller.”
Beverley Newbury, business director at VCCP Health, told PMLiVE: “We’re delighted to be working with the Mundipharma network of independent associated companies. It is particularly exciting to be working with a company that shares our dedication to innovative strategic thinking and commitment to outstanding creative.”
Mundipharma has achieved a string of successful product launches across European markets, bringing patients the benefits of new treatment options in pain, oncology and respiratory.